Search research articles
Contact Us
Filters
Showing results (21-30 of 148) with videos related to
Page
of 15
Sort By:
The Oncologist
|
February 3, 2004
Diagnosis and treatment of cholangiocarcinoma
Christopher D Anderson, C Wright Pinson, Jordan Berlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 8, 2018
The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience
Satya Das, Gino Pineda, Laura Goff, et al.
Human Pathology
|
October 18, 2017
Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti-PD-1/PD-L1 therapy
Jordan A Roberts, Raul S Gonzalez, Satya Das, et al.
American Journal of Clinical Pathology
|
August 20, 2017
Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?
Ramya Thota, Raul S Gonzalez, Jordan Berlin, et al.
Molecular Cancer Therapeutics
|
February 4, 2010
Aurora kinase inhibitors--rising stars in cancer therapeutics?
Altaf A Dar, Laura W Goff, Shahana Majid, et al.
Molecular Cancer
|
November 15, 2011
Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation
Kevin Vo, Barushi Amarasinghe, Kay Washington, et al.
Journal of Oncology and Cancer Research
|
August 8, 2019
Hidden Figures: Occult Intra-Cardiac Metastases in Asymptomatic Neuroendocrine Tumor Patients
Satya Das, Gino Pineda, Jordan Berlin, et al.
Research Square
|
May 15, 2024
Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision Oncology
Shannon S Stockton, G Dan Ayers, Cody Lee, et al.
JCO Oncology Practice
|
September 5, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline Clinical Insights
Aaron J Scott, Erin B Kennedy, Jordan Berlin, et al.
Investigational New Drugs
|
May 22, 2024
Evolving or immutable - phase I solid tumor trials in the era of precision oncology
Shannon S Stockton, G Dan Ayers, Cody Lee, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 148) with videos related to
Sort By:
Page
of 15
The Oncologist
|
February 3, 2004
Diagnosis and treatment of cholangiocarcinoma
Christopher D Anderson, C Wright Pinson, Jordan Berlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 8, 2018
The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience
Satya Das, Gino Pineda, Laura Goff, et al.
Human Pathology
|
October 18, 2017
Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti-PD-1/PD-L1 therapy
Jordan A Roberts, Raul S Gonzalez, Satya Das, et al.
American Journal of Clinical Pathology
|
August 20, 2017
Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?
Ramya Thota, Raul S Gonzalez, Jordan Berlin, et al.
Molecular Cancer Therapeutics
|
February 4, 2010
Aurora kinase inhibitors--rising stars in cancer therapeutics?
Altaf A Dar, Laura W Goff, Shahana Majid, et al.
Molecular Cancer
|
November 15, 2011
Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation
Kevin Vo, Barushi Amarasinghe, Kay Washington, et al.
Journal of Oncology and Cancer Research
|
August 8, 2019
Hidden Figures: Occult Intra-Cardiac Metastases in Asymptomatic Neuroendocrine Tumor Patients
Satya Das, Gino Pineda, Jordan Berlin, et al.
Research Square
|
May 15, 2024
Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision Oncology
Shannon S Stockton, G Dan Ayers, Cody Lee, et al.
JCO Oncology Practice
|
September 5, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline Clinical Insights
Aaron J Scott, Erin B Kennedy, Jordan Berlin, et al.
Investigational New Drugs
|
May 22, 2024
Evolving or immutable - phase I solid tumor trials in the era of precision oncology
Shannon S Stockton, G Dan Ayers, Cody Lee, et al.
Page
of 15